儿童顽固“湿疹”可能是特应性皮炎 非激素用药正式上市

2020-10-15 39健康网 39健康网

据统计,在我国约有7000-9000万特应性皮炎患者,其中中重度患者占到了30%,由剧烈瘙痒引起的睡眠缺失及心理问题严重影响着患者生活质量,同时也给患者家庭和社会带来巨大的经济负担。

你体验过瘙痒难耐吗?对于中重度特应性皮炎患者来说,从患上疾病的那一天就是一场“灾难”,这种瘙痒循环反复,一天持续12个小时,晚上一旦发作加剧让人彻夜难眠,狠心抓一把,都是带血的皮屑,对整个家庭来说都在经历一场噩梦!

“据统计,在我国约有7000-9000万特应性皮炎患者,其中中重度患者占到了30%,由剧烈瘙痒引起的睡眠缺失及心理问题严重影响着患者生活质量,同时也给患者家庭和社会带来巨大的经济负担。”在第三届中国康复医学会皮肤病康复专业委员会学术年会上,中国康复医学会皮肤病康复专委会主委张建中教授说道。

“儿童是该病的主要发病人群,传统治疗上外用糖皮质激素一度让许多家长忧心忡忡,近些年来,随着生物医药技术的飞速发展,新药的出现让皮肤科医生有了更多的选择。”张建中教授表示,面部皮炎、眼脸对称湿疹,掌纹加深,男性阴囊湿疹,白色皮划痕都是特应性皮炎的典型表现,需额外留意。

39健康获悉,大会期间,由中国康复医学会专家们倡议,辉瑞制药支持的中国AD关爱月科普系列活动-专家倡议备书仪式也于10月10日举行,旨在帮助更多的人了解特应性皮炎,掌握特应性皮炎的诊疗知识与技能,助力提高全民健康水平,并倡议从2021年开始,每年设定一个月为AD关注月。

中国康复医学会皮肤病康复专委会主委张建中教授表示:“近年来,随着国内对皮肤性病学基础研究的深入,我国在皮科领域的诊疗工作取得了一系列进展,不断有新技术、新成果达到国际领先水平,受到了国际一致的认可和赞许,不仅推动了我国皮肤病整体诊疗水平的飞跃发展,也提升了中国在全球皮肤病领域的影响力。未来,我们将继续深耕这一领域,争取研究出更多的科研成果,同时也要加强对特应性皮炎等皮肤病的科普宣教,将新成果应用于临床,以期造福更多皮肤病患者。”

特应性皮炎好发于儿童,以剧烈瘙痒为主要症状

皮肤是人体最大的器官,具有保护、排泄、调节体温和感受外界刺激等作用。与其他器官一样,皮肤也会生病且种类繁多,严重可危及生命。在众多的皮肤病中,特应性皮炎(AD)是一种慢性、复发性、炎症性皮肤病,通常初发于婴儿期,部分患者病情迁延至成年,以反复发作的剧烈瘙痒和皮疹为主要临床表现。与一般性的湿疹不同,AD患者常合并过敏性鼻炎、哮喘、代谢综合征等其他疾病的发生。

作为皮肤科常见的疾病,特应性皮炎已成为一个全球性的公共卫生问题。数据显示,全球高达10%的成人和20%的儿童患有AD。随着生活方式和环境的改变,近10余年我国AD患病率在不断上升,患者人群涉及各年龄段,尤其是1-7岁年龄段儿童AD发病率为12.94%,且年龄越小发病率越高,1岁以下儿童发病率更是高达30.48%。

“目前,AD的发病原因尚未明确,与遗传、环境等因素关系密切。遗传因素主要影响皮肤屏障功能与免疫平衡。而在环境因素上,气候变化、生活方式改变、不良情绪等都可能会诱发或加重AD。”张建中教授指出:“特应性皮炎病程长、易反复,使患者饱受瘙痒的折磨,甚至可引起睡眠不足、饮食限制、焦虑抑郁等问题,严重影响患者的生活与工作;特别是对于广大婴幼儿患者,AD可能会影响其成长发育、认识功能、注意力等,同时还会给整个家庭和社会带来巨大负担。

国际创新PDE-4抑制外用制剂-非甾体零激素为患者带来安全新选择

事实上,特应性皮炎虽然难以治愈,但若能及时规范诊疗,患者病情可以得到有效控制。目前,外用糖皮质激素为AD治疗的一线疗法,能够有效起到抗炎、止痒作用。但需要注意的是,长期大面积使用糖皮质激素可能会导致皮肤和系统不良反应,使得大部分家长不太愿意给孩子使用,无法满足患者的治疗需要。

近年来,随着生物医药技术的飞速发展,创新药PDE-4抑制剂的出现为广大儿童患者带来了希望。北京儿童医院皮肤科主任马琳教授表示:“PDE-4是AD炎症性细胞因子产生的关键调节点,主要通过降解环磷酸腺苷(cAMP)起作用。令人欣喜的是,国内已有创新药PDE-4抑制剂获批上市,通过控制炎症反应,可有效、迅速地缓解皮肤瘙痒,消除皮肤损伤等,避免了糖皮质激素的不良反应,有助于提高用药的依从性,为患者带来全新的治疗方案。”

北京儿童医院皮肤科主任马琳教授

为了进一步规范和指导特应性皮炎的诊断和治疗,中华医学会皮肤性病学分会免疫学组在今年2月发布了《中国特应性皮炎诊疗指南(2020)》,提出了特应性皮炎诊断的“中国标准”,并将PDE-4抑制剂纳入推荐用药。

广州市皮肤病防治所副所长朱慧兰教授

广州市皮肤病防治所副所长朱慧兰教授提醒道:“由于特应性皮炎是一种需要长期管理的慢性疾病,患者一定要遵循医嘱,坚持用药。除此之外,在日常生活中,AD患者保持居住环境的清洁,注意通风换气,室内温度适宜;合理饮食,避免食用容易引起过敏的食物,避免饮酒和辛辣食物;养成良好的卫生习惯,做好皮肤保湿工作,选用合适自己的保湿润肤剂;尽量选择纯棉面料的贴身衣物等,给予全方位的呵护管理,助力提升患者的生活质量。”

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1209140, encodeId=a4be12091404d, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e06a6525385, createdName=ms4000000065127311, createdTime=Thu Apr 07 07:27:45 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074602, encodeId=9a5d10e46023c, content=受教了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=114a6150123, createdName=ms7000001837964238, createdTime=Sat Nov 27 20:25:01 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951898, encodeId=c30d95189862, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c285474166, createdName=ms7000001355884240, createdTime=Sun Mar 28 18:08:14 CST 2021, time=2021-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892390, encodeId=913489239097, content=很多年前参加过特应性皮炎的会议,算是见证发展吗😂, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210315/480e12f811f44bc39b347d2521d56e86/67d0e6d503124ea685205b567af3dffd.jpg, createdBy=f9435296193, createdName=Baodongxu, createdTime=Fri Oct 16 09:17:40 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892349, encodeId=ee7389234995, content=想好好学习皮肤病学, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211028/9b9670e4f0f14174884f7247f527d0f1/ca29abf585ec4a1a96495ecdc3bf50f7.jpg, createdBy=e8675398491, createdName=ms8000000897014883, createdTime=Thu Oct 15 23:24:54 CST 2020, time=2020-10-15, status=1, ipAttribution=)]
    2022-04-07 ms4000000065127311

    受益匪浅

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1209140, encodeId=a4be12091404d, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e06a6525385, createdName=ms4000000065127311, createdTime=Thu Apr 07 07:27:45 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074602, encodeId=9a5d10e46023c, content=受教了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=114a6150123, createdName=ms7000001837964238, createdTime=Sat Nov 27 20:25:01 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951898, encodeId=c30d95189862, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c285474166, createdName=ms7000001355884240, createdTime=Sun Mar 28 18:08:14 CST 2021, time=2021-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892390, encodeId=913489239097, content=很多年前参加过特应性皮炎的会议,算是见证发展吗😂, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210315/480e12f811f44bc39b347d2521d56e86/67d0e6d503124ea685205b567af3dffd.jpg, createdBy=f9435296193, createdName=Baodongxu, createdTime=Fri Oct 16 09:17:40 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892349, encodeId=ee7389234995, content=想好好学习皮肤病学, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211028/9b9670e4f0f14174884f7247f527d0f1/ca29abf585ec4a1a96495ecdc3bf50f7.jpg, createdBy=e8675398491, createdName=ms8000000897014883, createdTime=Thu Oct 15 23:24:54 CST 2020, time=2020-10-15, status=1, ipAttribution=)]
    2021-11-27 ms7000001837964238

    受教了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1209140, encodeId=a4be12091404d, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e06a6525385, createdName=ms4000000065127311, createdTime=Thu Apr 07 07:27:45 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074602, encodeId=9a5d10e46023c, content=受教了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=114a6150123, createdName=ms7000001837964238, createdTime=Sat Nov 27 20:25:01 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951898, encodeId=c30d95189862, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c285474166, createdName=ms7000001355884240, createdTime=Sun Mar 28 18:08:14 CST 2021, time=2021-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892390, encodeId=913489239097, content=很多年前参加过特应性皮炎的会议,算是见证发展吗😂, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210315/480e12f811f44bc39b347d2521d56e86/67d0e6d503124ea685205b567af3dffd.jpg, createdBy=f9435296193, createdName=Baodongxu, createdTime=Fri Oct 16 09:17:40 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892349, encodeId=ee7389234995, content=想好好学习皮肤病学, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211028/9b9670e4f0f14174884f7247f527d0f1/ca29abf585ec4a1a96495ecdc3bf50f7.jpg, createdBy=e8675398491, createdName=ms8000000897014883, createdTime=Thu Oct 15 23:24:54 CST 2020, time=2020-10-15, status=1, ipAttribution=)]
    2021-03-28 ms7000001355884240

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1209140, encodeId=a4be12091404d, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e06a6525385, createdName=ms4000000065127311, createdTime=Thu Apr 07 07:27:45 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074602, encodeId=9a5d10e46023c, content=受教了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=114a6150123, createdName=ms7000001837964238, createdTime=Sat Nov 27 20:25:01 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951898, encodeId=c30d95189862, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c285474166, createdName=ms7000001355884240, createdTime=Sun Mar 28 18:08:14 CST 2021, time=2021-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892390, encodeId=913489239097, content=很多年前参加过特应性皮炎的会议,算是见证发展吗😂, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210315/480e12f811f44bc39b347d2521d56e86/67d0e6d503124ea685205b567af3dffd.jpg, createdBy=f9435296193, createdName=Baodongxu, createdTime=Fri Oct 16 09:17:40 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892349, encodeId=ee7389234995, content=想好好学习皮肤病学, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211028/9b9670e4f0f14174884f7247f527d0f1/ca29abf585ec4a1a96495ecdc3bf50f7.jpg, createdBy=e8675398491, createdName=ms8000000897014883, createdTime=Thu Oct 15 23:24:54 CST 2020, time=2020-10-15, status=1, ipAttribution=)]
    2020-10-16 Baodongxu

    很多年前参加过特应性皮炎的会议,算是见证发展吗😂

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1209140, encodeId=a4be12091404d, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e06a6525385, createdName=ms4000000065127311, createdTime=Thu Apr 07 07:27:45 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074602, encodeId=9a5d10e46023c, content=受教了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=114a6150123, createdName=ms7000001837964238, createdTime=Sat Nov 27 20:25:01 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951898, encodeId=c30d95189862, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c285474166, createdName=ms7000001355884240, createdTime=Sun Mar 28 18:08:14 CST 2021, time=2021-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892390, encodeId=913489239097, content=很多年前参加过特应性皮炎的会议,算是见证发展吗😂, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210315/480e12f811f44bc39b347d2521d56e86/67d0e6d503124ea685205b567af3dffd.jpg, createdBy=f9435296193, createdName=Baodongxu, createdTime=Fri Oct 16 09:17:40 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892349, encodeId=ee7389234995, content=想好好学习皮肤病学, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211028/9b9670e4f0f14174884f7247f527d0f1/ca29abf585ec4a1a96495ecdc3bf50f7.jpg, createdBy=e8675398491, createdName=ms8000000897014883, createdTime=Thu Oct 15 23:24:54 CST 2020, time=2020-10-15, status=1, ipAttribution=)]
    2020-10-15 ms8000000897014883

    想好好学习皮肤病学

    0

相关资讯

J Allergy Clin Immunol:尼莫利珠单抗可快速持续改善特应性皮炎患者的皮肤炎症和瘙痒症状

尼莫利珠单抗靶向特应性皮炎(AD)中的IL-31受体α亚单位。本研究旨在评估奈莫利珠单抗在AD患者中的新用药策略。

Clin Oral Investig:研究揭示CHI3L1在特应性皮炎发生和进展中的作用

特应性皮炎(AD)是一种以皮肤屏障缺陷和Th2免疫反应为特征的慢性炎症性皮肤病。壳蛋白酶3-样 1(CHI3L1),在小鼠中也被称为乳腺回归蛋白39(BRP-39)和人类同源物YKL-40,在Th2炎

Lancet:abrocitinib单药用于中重度特应性皮炎的治疗

对于青少年和成人中度至重度特应性皮炎患者,每日一次口服abrocitinib是有效且耐受性良好的

JAK抑制剂Rinvoq治疗特应性皮炎:III期临床疗效显著

接受15mg/30mg两种剂量Rinvoq治疗的患者,皮肤清除率和瘙痒减轻比例明显增加,分别有60%和73%的患者达到EASI 75,而安慰剂组为13%。

国家药监局批准非激素外用PDE4抑制剂舒坦明(克立硼罗)用于特应性皮炎治疗

辉瑞(Pfizer)近日宣布,中国国家药品监督管理局(NMPA)已正式批准舒坦明(克立硼罗)2%软膏剂的进口药品注册证。舒坦明在中国被批准用于2岁及以上轻度至中度特应性皮炎(AD)患者的局部外用治疗。

J Invest Dermatol:Dupilumab对IL-4Rα的阻断作用可降低特应性皮炎患者皮肤上金葡菌的定植并增加微生物的多样性

Dupilumab是一种白细胞介素-4受体α的全人抗体,可改善中度至重度特应性皮炎(AD)的症状和体征。一项双盲、安慰剂对照研究旨在确定杜匹鲁单抗对皮肤上金黄色葡萄球菌定植和微生物多样性的